Contemporary American and European Guidelines for Heart Failure Management
JACC: Heart Failure · 2024-05 · 12 (5) · 810-825
DOI: 10.1016/j.jchf.2024.02.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Heart Failure, 2024-05. Verfasst von John W Ostrominski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Endocrinology, Dia…. Hauptthemen laut MEDLINE: Heart Failure, Practice Guidelines as Topic. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
This review serves to compare contemporary clinical practice recommendations for the management of heart failure (HF), as codified in the 2021 European Society of Cardiology (ESC) guideline, the 2022 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Failure Society of America (HFSA) guideline, and the 2023 focused update of the 2021 ESC document. Overall, these guidelines aim to solidify significant advances throughout the HF continuum since the publication of previous full guideline iterations (2013 and 2016 for the ACC/AHA and ESC, respectively). All guidelines provide new recommendations for an increasingly complex landscape of HF care, with focus on primary HF prevention, HF stages, rapid initiation and optimization of evidence-based pharmacotherapies, overlapping cardiac and noncardiac comorbidities, device-based therapies, and management pathways for special groups of patients, including those with cardiac amyloidosis. Importantly, the ACC/AHA/HFSA document features special emphasis on HF risk prediction and screening, cost/value, social determinants of health, and health care disparities. The review discusses major similarities and differences between these recent guidelines and guideline updates, as well as their potential downstream implications for clinical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical…
- Division of Cardiology, Center for Advanced Cardiac Care, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA.
- Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut, USA.
- Winters Center for Heart Failure, Cardiovascular Research Institute, Baylor College of Medicine and DeBakey VA Medical Center, Houston, Texas, USA.
- Department of Medicine, VA Palo Alto Healthcare System, Palo Alto, California, USA.
Zitieren
APA
Ostrominski, J. W., DeFilippis, E. M., Bansal, K., Riello, R. J., Bozkurt, B., Heidenreich, P. A., & Vaduganathan, M. (2024). Contemporary American and European Guidelines for Heart Failure Management. JACC: Heart Failure, 12(5), 810-825. https://doi.org/10.1016/j.jchf.2024.02.020
Vancouver
Ostrominski JW, DeFilippis EM, Bansal K, Riello RJ, Bozkurt B, Heidenreich PA, et al. Contemporary American and European Guidelines for Heart Failure Management. JACC: Heart Failure. 2024;12(5):810-825. doi:10.1016/j.jchf.2024.02.020
BibTeX
@article{Ostrominski2024,
author = {Ostrominski, John W and DeFilippis, Ersilia M and Bansal, Kannu and Riello, Ralph J and Bozkurt, Biykem and Heidenreich, Paul A and Vaduganathan, Muthiah},
title = {Contemporary American and European Guidelines for Heart Failure Management},
journal = {JACC: Heart Failure},
year = {2024},
volume = {12},
number = {5},
pages = {810--825},
doi = {10.1016/j.jchf.2024.02.020}
}
EUVIMED